{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:42:13Z","timestamp":1776854533159,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Shanghai S&T Innovation Plan","award":["17401970900"],"award-info":[{"award-number":["17401970900"]}]},{"name":"Graduate Innovation Ability Project of Shanghai University of Traditional Chinese Medicine","award":["B201704"],"award-info":[{"award-number":["B201704"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biopha.2020.110619","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T13:45:44Z","timestamp":1597153544000},"page":"110619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Relationship between antofloxacin concentration and QT prolongation and estimation of the possible false-positive rate"],"prefix":"10.1016","volume":"130","author":[{"given":"Li-yu","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-chun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-han","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-shan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2020.110619_bib0005","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40264-015-0316-6","article-title":"Pharmacogenetics of drug-induced QT interval prolongation: an update","volume":"38","author":"Niemeijer","year":"2015","journal-title":"Drug Saf."},{"issue":"12","key":"10.1016\/j.biopha.2020.110619_bib0010","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","article-title":"QT interval prolongation and the risk of torsades de pointes: essentials for clinicians","volume":"29","author":"Trinkley","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"issue":"13","key":"10.1016\/j.biopha.2020.110619_bib0015","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes","volume":"67","author":"Schwartz","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110619_bib0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.biopha.2020.110619_bib0025","first-page":"523","article-title":"Drug induced QT prolongation","volume":"14","author":"Zareba","year":"2007","journal-title":"Cardiol. J."},{"issue":"2","key":"10.1016\/j.biopha.2020.110619_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000334441","article-title":"QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications","volume":"120","author":"Briasoulis","year":"2011","journal-title":"Cardiology"},{"issue":"5","key":"10.1016\/j.biopha.2020.110619_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155649","article-title":"Co-prescription of QT-Interval prolonging drugs: an analysis in a large cohort of geriatric patients","volume":"11","author":"Sch\u00e4chtele","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2020.110619_bib0040","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of Torsade De Pointes in hospital settings: a scientific statement from the american heart association and the american college of cardiology foundation","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2020.110619_bib0045","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","author":"Gupta","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.biopha.2020.110619_bib0050","series-title":"E14 the Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs","author":"International Conference on Harmonization","year":"2005"},{"issue":"11","key":"10.1016\/j.biopha.2020.110619_bib0055","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/aps.2017.76","article-title":"Population pharmacokinetics of moxifloxacin and its concentration-QT interval relationship modeling in Chinese healthy volunteers","volume":"38","author":"Xu","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.biopha.2020.110619_bib0060","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/aps.2014.153","article-title":"Orally administered moxifloxacin prolongs QTc in healthy Chinese volunteers: a randomized, single-blind, crossover study","volume":"36","author":"Chen","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2020.110619_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/clpt.2011.224","article-title":"The cost-effectiveness of drug regulation: the example of thorough QT\/QTc studies","volume":"91","author":"Bouvy","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2020.110619_bib0070","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/europace\/euv405","volume":"18","author":"Baumert","year":"2016","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.biopha.2020.110619_bib0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10928-017-9558-5","article-title":"Scientific white paper on concentration-QTc modeling","volume":"45","author":"Garnett","year":"2018","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"17","key":"10.1016\/j.biopha.2020.110619_bib0080","doi-asserted-by":"crossref","first-page":"E638","DOI":"10.1503\/cmaj.160938","article-title":"Fluoroquinolone antimicrobial drugs","volume":"189","author":"Chan","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.biopha.2020.110619_bib0085","first-page":"112","article-title":"Antibacterial activities of the derivatives-YH54 and YH57 of levofloxacin in vitro","volume":"18","author":"Ye","year":"2002","journal-title":"Chin Pharmacol Bull"},{"issue":"11","key":"10.1016\/j.biopha.2020.110619_bib0090","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/aps.2012.68","article-title":"Dose findings of antofloxacin hydrochloride for treating bacterial infections in an early clinical trial using PK-PD parameters in healthy volunteers","volume":"33","author":"Li","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.biopha.2020.110619_bib0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000317581","article-title":"A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections","volume":"56","author":"Wang","year":"2010","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1016\/j.biopha.2020.110619_bib0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/bdd.600","article-title":"Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers","volume":"29","author":"Xiao","year":"2008","journal-title":"Biopharm. Drug Dispos."},{"issue":"2","key":"10.1016\/j.biopha.2020.110619_bib0105","first-page":"242","article-title":"Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers","volume":"124","author":"L\u00fc","year":"2011","journal-title":"Chin. Med. J."},{"issue":"4","key":"10.1016\/j.biopha.2020.110619_bib0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5414\/CPP46172","article-title":"Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers","volume":"46","author":"Xiao","year":"2008","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2020.110619_bib0115","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/aps.2011.78","article-title":"Modulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans","volume":"32","author":"Liu","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2020.110619_bib0120","first-page":"353","article-title":"An analysis of the time\u2010relations of the electrocardiograms","volume":"7","author":"HC","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.biopha.2020.110619_bib0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","article-title":"Die systolendauer im elektrokardiogramm bei normalen menschen und bei herzkranken","volume":"53","author":"LS","year":"1920","journal-title":"Acta Med. Scand."},{"issue":"3","key":"10.1016\/j.biopha.2020.110619_bib0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/hrt.55.3.253","article-title":"Diurnal variation of the QT interval--influence of the autonomic nervous system","volume":"55","author":"Bexton","year":"1986","journal-title":"Br. Heart J."},{"issue":"4","key":"10.1016\/j.biopha.2020.110619_bib0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9149(92)90230-V","article-title":"Role of sympathovagal interaction in diurnal variation of QT interval","volume":"69","author":"Murakawa","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2020.110619_bib0140","series-title":"The Assessment of the Potential for QT Interval Prolongation by Non-cardiovascular Medical Products","author":"Committee for Proprietary Medical Products of the European Agency for the Evaluation of Medical Products","year":"1997"},{"issue":"5","key":"10.1016\/j.biopha.2020.110619_bib0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0042-103329","article-title":"Population pharmacokinetics of Lithium carbonate in young male healthy chinese volunteers","volume":"49","author":"Yu","year":"2016","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2020.110619_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.251","article-title":"Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson\u2019s disease","volume":"4","author":"Loprete","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.biopha.2020.110619_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.12793\/tcp.2018.26.1.25","article-title":"Population pharmacokinetic analysis of metformin administered as fixed-dose combination in Korean healthy adults","volume":"26","author":"Choi","year":"2018","journal-title":"Transl. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110619_bib0160","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ahj.2010.09.002","article-title":"The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing","volume":"160","author":"Kligfield","year":"2010","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.biopha.2020.110619_bib0165","first-page":"69","article-title":"Statistics corner: a guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med. J."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222030812X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222030812X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:07:06Z","timestamp":1766081226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222030812X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":33,"alternative-id":["S075333222030812X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110619","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between antofloxacin concentration and QT prolongation and estimation of the possible false-positive rate","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110619"}}